Tarsons Products Limited

NSE:TARSONS India Medical Instruments & Supplies
Market Cap
$115.90 Million
₹10.04 Billion INR
Market Cap Rank
#24908 Global
#1305 in India
Share Price
₹188.65
Change (1 day)
-0.65%
52-Week Range
₹185.49 - ₹442.55
All Time High
₹867.38
About

Tarsons Products Limited manufactures and trades in scientific plastic labware products in India and internationally. The company offers bottles and carboys; boxes and racks; cell cell culture ware, centrifuge ware, clamps and stands, cryoware, desiccator, tubings and connectors, filtration, genomics and PCR consumables, laboratory equipment and utilities, liquid handling consumables and reusable… Read more

Tarsons Products Limited (TARSONS) - Total Assets

Latest total assets as of September 2025: ₹11.64 Billion INR

Based on the latest financial reports, Tarsons Products Limited (TARSONS) holds total assets worth ₹11.64 Billion INR as of September 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Tarsons Products Limited - Total Assets Trend (2019–2025)

This chart illustrates how Tarsons Products Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Tarsons Products Limited - Asset Composition Analysis

Current Asset Composition (March 2025)

Tarsons Products Limited's total assets of ₹11.64 Billion consist of 22.5% current assets and 77.5% non-current assets.

Asset Category Amount (INR) % of Total Assets
Cash & Equivalents ₹0.00 2.3%
Accounts Receivable ₹796.16 Million 7.4%
Inventory ₹1.26 Billion 11.7%
Property, Plant & Equipment ₹0.00 0.0%
Intangible Assets ₹317.42 Million 2.9%
Goodwill ₹325.25 Million 3.0%

Asset Composition Trend (2019–2025)

This chart illustrates how Tarsons Products Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Tarsons Products Limited's current assets represent 22.5% of total assets in 2025, a decrease from 45.8% in 2019.
  • Cash Position: Cash and equivalents constituted 2.3% of total assets in 2025, up from 0.2% in 2019.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, an increase from 0.0% in 2019.
  • Asset Diversification: The largest asset category is inventory at 11.7% of total assets.

Tarsons Products Limited Competitors by Total Assets

Key competitors of Tarsons Products Limited based on total assets are shown below.

Company Country Total Assets
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
China CN¥3.82 Billion
Blue Sail Medical Co Ltd
SHE:002382
China CN¥16.46 Billion
Andon Health Co Ltd
SHE:002432
China CN¥28.98 Billion
Allmed Medical Products Co Ltd Class A
SHE:002950
China CN¥5.35 Billion
Inix Technologies Holdings Bhd
KLSE:0094
Malaysia RM72.53 Million
Focus Point Holdings Bhd
KLSE:0157
Malaysia RM328.19 Million
Careplus Group Bhd
KLSE:0163
Malaysia RM286.61 Million
LKL International Bhd
KLSE:0182
Malaysia RM173.46 Million

Tarsons Products Limited - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.30 - 0.84

Lower asset utilization - Tarsons Products Limited generates 0.36x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: 2.76% - 23.27%

Moderate ROA - For every $100 in assets, Tarsons Products Limited generates $ 2.76 in net profit.

Tarsons Products Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.03 1.19 2.70
Quick Ratio 0.48 0.56 1.58
Cash Ratio 0.00 0.00 0.00
Working Capital ₹62.83 Million ₹ 427.58 Million ₹ 710.03 Million

Tarsons Products Limited - Advanced Valuation Insights

This section examines the relationship between Tarsons Products Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.71
Latest Market Cap to Assets Ratio 0.00
Asset Growth Rate (YoY) 11.1%
Total Assets ₹10.80 Billion
Market Capitalization $22.74 Million USD

Valuation Analysis

Below Book Valuation: The market values Tarsons Products Limited's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Tarsons Products Limited's assets grew by 11.1% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Tarsons Products Limited (2019–2025)

The table below shows the annual total assets of Tarsons Products Limited from 2019 to 2025.

Year Total Assets Change
2025-03-31 ₹10.80 Billion +11.09%
2024-03-31 ₹9.72 Billion +33.97%
2023-03-31 ₹7.26 Billion +33.34%
2022-03-31 ₹5.44 Billion +83.89%
2021-03-31 ₹2.96 Billion +19.00%
2020-03-31 ₹2.49 Billion +17.34%
2019-03-31 ₹2.12 Billion --